The researchers injected the four cows with
an HIV immunogen, a molecule that can prompt the HIV immune response.
Not exact matches
Using the findings from this study, the team has designed vaccine
immunogens to selectively trigger the cooperating antibody - producing B cells to cooperate to make broadly neutralizing antibodies in a manner that mimics broadly neutralizing antibody development in natural
HIV infection.
Immunogens are designed to elicit the production of highly coveted broadly neutralizing antibodies that protect against
HIV - 1 [Also see Report by McGuire et al..]
A major goal of
HIV - 1 vaccine development is to identify
immunogens capable of inducing protective titers of broadly neutralizing antibodies (bNAbs) against circulating, neutralization - resistant (tier 2) viruses.
A critical implication of this work for the field of
HIV vaccine design is the observation that the most potent and broad individual anti-
HIV VHH, J3, was elicited in response to the gp140
immunogens used.
Dr. Schief's work focuses on computation - guided and structure - based design of
immunogens and immunization regimens, with the goal of inducing broadly neutralizing antibodies against
HIV and other pathogens that have frustrated traditional vaccine design strategies.
«Although cows are not humans, these data provide important insights on how the immune system responds to
HIV [
immunogens],» Barouchs did not take part in the research.
The first
immunogens are those similar to the trimer outer Envelope protein of native
HIV.
Researchers are making progress in developing vaccine
immunogens designed to induce broadly neutralizing antibodies (bNAbs) against
HIV.